Resmed Inc. buy KeyCorp
Start price
31.01.25
/
50%
€232.00
Target price
31.01.26
€269.28
Performance (%)
-9.91%
Price
30.12.25
€208.50
Summary
This prediction is currently active. With a performance of -9.91%, the BUY prediction for Resmed Inc. by KeyCorp is down slightly. Dividends of €0.51 are taken into consideration when calculating the performance. This prediction currently runs until 31.01.26. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.530% | 0.530% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $266.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat